990 News Items found

Focal Therapy for Localized Prostate Cancer: Hope or Hype?

Urologist Peter Scardino discusses focal therapy for localized prostate cancer....

  • Wednesday, May 27, 2015
  • MedPage Today

Managing Breast Cancer in 2015: A Conversation with Larry Norton, MD

Medical oncologist Larry Norton discusses the current state of breast cancer research and therapy....

  • Wednesday, May 27, 2015
  • The ASCO Post

Link Found Between Breast-Cancer Genes, Prostate Cancer

Physician scientist Charles Sawyers discusses his research published in Cell which found that mutations in two genes well known for increasing th...

  • Thursday, May 21, 2015
  • The Wall Street Journal


Medical oncologist Mark Kris discusses Memorial Sloan Kettering's collaboration with IBM Watson in New York Magazine. ...

  • Wednesday, May 20, 2015
  • New York Magazine

Major Donations Bolster Hospital, Medical Research

Memorial Sloan Kettering Cancer Center announced a $150 million gift from Mr. David H. Koch. His donation will fund the construction of a $1...

  • Wednesday, May 20, 2015
  • The Wall Street Journal

Study Suggests Dense Breast Tissue Isn’t Always a High Cancer Risk

Radiologist Carol Lee discusses a new study that looks at mammograms for those with dense breasts in The New York Times. ...

  • Tuesday, May 19, 2015
  • The New York Times

How Doctors Deliver Bad News

Medical oncologist Andrew Epstein speaks with The Wall Street Journal about how doctors at Memorial Sloan Kettering are trained to deliver bad news to...

  • Monday, May 18, 2015
  • The Wall Street Journal

Screening: Early Alert

Biostatistician Ann Zauber discusses screening for colorectal cancer in Nature.   ...

  • Wednesday, May 13, 2015
  • Nature

Why We’re Teaching Computers to Diagnose Cancer

Medical oncologist Mark Kris discusses Memorial Sloan Kettering's collaboration with IBM Watson.   ...

  • Wednesday, May 13, 2015
  • PBS NewsHour

Lynparza, First In A New Class Of Cancer Drugs, Is Surprisingly Active In A Wide Range Of Tumors

Medical oncologist Mark Robson discusses PARP inhibitors in Forbes. ...

  • Monday, May 4, 2015
  • Forbes